Search research articles
Contact Us
Filters
Showing results (211-220 of 235) with videos related to
Page
of 24
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
European School of Oncology. First Euro-American Forum on Lung Cancer Treatment
P A Bunn, N Van Zandwijk, U Pastorino, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1981
Cyclophosphamide and dimethylsulfoxide in the treatment of squamous carcinoma of the lung. Therapeutic efficacy, toxicity, and pharmacokinetics
J Z Fuks, M J Egorin, J Aisner, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Carboplatin in malignant mesothelioma: a phase II study of the Cancer and Leukemia Group B
N J Vogelzang, M Goutsou, J M Corson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1992
Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study
J Aisner, M Goutsou, L H Maurer, et al.
Seminars in Oncology
|
October 1, 1995
Pharmacokinetics of paclitaxel and carboplatin in combination
C M Kearns, C P Belani, K Erkmen, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1982
Phase II evaluation and plasma pharmacokinetics of high-dose intravenous 6-thioguanine in patients with colorectal carcinoma
P H Konits, M J Egorin, D A Van Echo, et al.
Cancer
|
April 29, 1998
Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B
B L Samuels, J E Herndon, D C Harmon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1993
Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B
A P Chahinian, K Antman, M Goutsou, et al.
Journal of Clinical Pharmacology
|
August 1, 1981
Initial observations on the effects of delta 9-tetrahydrocannabinol on the plasma pharmacokinetics of cyclophosphamide and doxorubicin
C E Riggs, M J Egorin, J Z Fuks, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
July 1, 1993
Immunomodulation of interleukin-2 by cyclophosphamide: a phase IB trial
J S Abrams, J L Eiseman, T J Melink, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 235) with videos related to
Sort By:
Page
of 24
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
European School of Oncology. First Euro-American Forum on Lung Cancer Treatment
P A Bunn, N Van Zandwijk, U Pastorino, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1981
Cyclophosphamide and dimethylsulfoxide in the treatment of squamous carcinoma of the lung. Therapeutic efficacy, toxicity, and pharmacokinetics
J Z Fuks, M J Egorin, J Aisner, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Carboplatin in malignant mesothelioma: a phase II study of the Cancer and Leukemia Group B
N J Vogelzang, M Goutsou, J M Corson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1992
Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study
J Aisner, M Goutsou, L H Maurer, et al.
Seminars in Oncology
|
October 1, 1995
Pharmacokinetics of paclitaxel and carboplatin in combination
C M Kearns, C P Belani, K Erkmen, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1982
Phase II evaluation and plasma pharmacokinetics of high-dose intravenous 6-thioguanine in patients with colorectal carcinoma
P H Konits, M J Egorin, D A Van Echo, et al.
Cancer
|
April 29, 1998
Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B
B L Samuels, J E Herndon, D C Harmon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1993
Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B
A P Chahinian, K Antman, M Goutsou, et al.
Journal of Clinical Pharmacology
|
August 1, 1981
Initial observations on the effects of delta 9-tetrahydrocannabinol on the plasma pharmacokinetics of cyclophosphamide and doxorubicin
C E Riggs, M J Egorin, J Z Fuks, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
July 1, 1993
Immunomodulation of interleukin-2 by cyclophosphamide: a phase IB trial
J S Abrams, J L Eiseman, T J Melink, et al.
Page
of 24